SFAN

Based in Normandy, SFAN Laboratory was acquired in 2015 by Michel Brémont. Since then, it has established itself as a leading French player in the contract manufacturing of liquid galenic forms for food supplements (ampoules, bottles, shots, etc.), known for their complexity, particularly in terms of organoleptic and microbiological stability.

SFAN stands out for its unique expertise in natural ingredients, with proprietary plant maceration capabilities, agile R&D, and industrial excellence. The company launches around 100 new products each year, providing its clients with powerful levers for innovation and differentiation. Already well established in France, SFAN is now accelerating its international expansion, particularly in Asia – and especially in China – where demand for natural and innovative health solutions is experiencing strong growth.

This majority stake in SFAN is fully aligned with Vivalto Partners’ strategy of supporting visionary entrepreneurs and innovative healthcare companies in a true partnership approach, providing them with both financial and operational resources.

« We are delighted to welcome Vivalto Partners as shareholders. Their sector expertise and long-term vision make them the ideal partner for this new chapter in our history. »

Michel Brémont, Président of SFAN Laboratoire